160 related articles for article (PubMed ID: 1992167)
1. Refined crystal structures of subtilisin novo in complex with wild-type and two mutant eglins. Comparison with other serine proteinase inhibitor complexes.
Heinz DW; Priestle JP; Rahuel J; Wilson KS; Grütter MG
J Mol Biol; 1991 Jan; 217(2):353-71. PubMed ID: 1992167
[TBL] [Abstract][Full Text] [Related]
2. Changing the inhibitory specificity and function of the proteinase inhibitor eglin c by site-directed mutagenesis: functional and structural investigation.
Heinz DW; Hyberts SG; Peng JW; Priestle JP; Wagner G; Grütter MG
Biochemistry; 1992 Sep; 31(37):8755-66. PubMed ID: 1390662
[TBL] [Abstract][Full Text] [Related]
3. Molecular dynamics refinement of a thermitase-eglin-c complex at 1.98 A resolution and comparison of two crystal forms that differ in calcium content.
Gros P; Betzel C; Dauter Z; Wilson KS; Hol WG
J Mol Biol; 1989 Nov; 210(2):347-67. PubMed ID: 2689655
[TBL] [Abstract][Full Text] [Related]
4. Structural comparison of two serine proteinase-protein inhibitor complexes: eglin-c-subtilisin Carlsberg and CI-2-subtilisin Novo.
McPhalen CA; James MN
Biochemistry; 1988 Aug; 27(17):6582-98. PubMed ID: 3064813
[TBL] [Abstract][Full Text] [Related]
5. The high-resolution X-ray crystal structure of the complex formed between subtilisin Carlsberg and eglin c, an elastase inhibitor from the leech Hirudo medicinalis. Structural analysis, subtilisin structure and interface geometry.
Bode W; Papamokos E; Musil D
Eur J Biochem; 1987 Aug; 166(3):673-92. PubMed ID: 3301348
[TBL] [Abstract][Full Text] [Related]
6. Active site binding loop stabilization in the subtilisin inhibitor eglin c: structural and functional studies on specifically designed mutants in complex with subtilisin and the uncomplexed inhibitor.
Hipler K; Priestle JP; Rahuel J; Grütter MG
Adv Exp Med Biol; 1996; 379():43-7. PubMed ID: 8796309
[TBL] [Abstract][Full Text] [Related]
7. Refined 1.2 A crystal structure of the complex formed between subtilisin Carlsberg and the inhibitor eglin c. Molecular structure of eglin and its detailed interaction with subtilisin.
Bode W; Papamokos E; Musil D; Seemueller U; Fritz H
EMBO J; 1986 Apr; 5(4):813-8. PubMed ID: 3519213
[TBL] [Abstract][Full Text] [Related]
8. Effects of eglin-c binding to thermitase: three-dimensional structure comparison of native thermitase and thermitase eglin-c complexes.
Gros P; Teplyakov AV; Hol WG
Proteins; 1992 Jan; 12(1):63-74. PubMed ID: 1553381
[TBL] [Abstract][Full Text] [Related]
9. Structure of the proteinase inhibitor eglin c with hydrolysed reactive centre at 2.0 A resolution.
Betzel C; Dauter Z; Genov N; Lamzin V; Navaza J; Schnebli HP; Visanji M; Wilson KS
FEBS Lett; 1993 Feb; 317(3):185-8. PubMed ID: 8425603
[TBL] [Abstract][Full Text] [Related]
10. Crystal and molecular structure of the inhibitor eglin from leeches in complex with subtilisin Carlsberg.
McPhalen CA; Schnebli HP; James MN
FEBS Lett; 1985 Aug; 188(1):55-8. PubMed ID: 3926539
[TBL] [Abstract][Full Text] [Related]
11. Probing intermolecular backbone H-bonding in serine proteinase-protein inhibitor complexes.
Lu W; Randal M; Kossiakoff A; Kent SB
Chem Biol; 1999 Jul; 6(7):419-27. PubMed ID: 10381402
[TBL] [Abstract][Full Text] [Related]
12. Binding of the recombinant proteinase inhibitor eglin c from leech Hirudo medicinalis to human leukocyte elastase, bovine alpha-chymotrypsin and subtilisin Carlsberg: thermodynamic study.
Ascenzi P; Amiconi G; Menegatti E; Guarneri M; Bolognesi M; Schnebli HP
J Enzyme Inhib; 1988; 2(3):167-72. PubMed ID: 3071573
[TBL] [Abstract][Full Text] [Related]
13. Deciphering the role of the electrostatic interactions involving Gly70 in eglin C by total chemical protein synthesis.
Lu WY; Starovasnik MA; Dwyer JJ; Kossiakoff AA; Kent SB; Lu W
Biochemistry; 2000 Apr; 39(13):3575-84. PubMed ID: 10736156
[TBL] [Abstract][Full Text] [Related]
14. X-ray crystal structure of the serine proteinase inhibitor eglin c at 1.95 A resolution.
Hipler K; Priestle JP; Rahuel J; Grütter MG
FEBS Lett; 1992 Sep; 309(2):139-45. PubMed ID: 1505678
[TBL] [Abstract][Full Text] [Related]
15. Complex between the subtilisin from a mesophilic bacterium and the leech inhibitor eglin-C.
Dauter Z; Betzel C; Genov N; Pipon N; Wilson KS
Acta Crystallogr B; 1991 Oct; 47 ( Pt 5)():707-30. PubMed ID: 1793542
[TBL] [Abstract][Full Text] [Related]
16. Kinetics of the inhibition of human pancreatic elastase by recombinant eglin c. Influence of elastin.
Faller B; Dirrig S; Rabaud M; Bieth JG
Biochem J; 1990 Sep; 270(3):639-44. PubMed ID: 1700695
[TBL] [Abstract][Full Text] [Related]
17. NMR structure of CmPI-II, a non-classical Kazal protease inhibitor: Understanding its conformational dynamics and subtilisin A inhibition.
Cabrera-Muñoz A; Valiente PA; Rojas L; Alonso-Del-Rivero Antigua M; Pires JR
J Struct Biol; 2019 Jun; 206(3):280-294. PubMed ID: 30930219
[TBL] [Abstract][Full Text] [Related]
18. X-ray crystal structure of the bovine alpha-chymotrypsin/eglin c complex at 2.6 A resolution.
Bolognesi M; Pugliese L; Gatti G; Frigerio F; Coda A; Antolini L; Schnebli HP; Menegatti E; Amiconi G; Ascenzi P
J Mol Recognit; 1990 Aug; 3(4):163-8. PubMed ID: 2278733
[TBL] [Abstract][Full Text] [Related]
19. Crystal and molecular structure of the bovine alpha-chymotrypsin-eglin c complex at 2.0 A resolution.
Frigerio F; Coda A; Pugliese L; Lionetti C; Menegatti E; Amiconi G; Schnebli HP; Ascenzi P; Bolognesi M
J Mol Biol; 1992 May; 225(1):107-23. PubMed ID: 1583684
[TBL] [Abstract][Full Text] [Related]
20. Binding of the recombinant proteinase inhibitor eglin c from leech Hirudo medicinalis to serine (pro)enzymes: a comparative thermodynamic study.
Ascenzi P; Aducci P; Amiconi G; Ballio A; Guaragna A; Menegatti E; Schnebli HP; Bolognesi M
J Mol Recognit; 1991; 4(4):113-9. PubMed ID: 1799460
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
